USPTO serial 87981379
BIOMED B
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 6, 2019
- Examiner
- BUTLER, MIDGE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with BIOMED B?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
BIOMED INTERNATIONAL PRODUCTS CORPORATION
Burnaby, BC, CA
Other trademarks owned by BIOMED INTERNATIONAL PRODUCTS CORPORATION
BIOMED INTERNATIONAL PRODUCTS CORPORATION
Burnaby, BC, CA
Other trademarks owned by BIOMED INTERNATIONAL PRODUCTS CORPORATION
BIOMED INTERNATIONAL PRODUCTS CORPORATION
Burnaby, BC, CA
Other trademarks owned by BIOMED INTERNATIONAL PRODUCTS CORPORATION
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steve Zemanick
Steve Zemanick Four Reasons Legal8074 E 34th AveDenver, CO 80238United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ magnesium hydroxide; calcium; iron salts; magnesium citrate ] | SECTION 8 - CANCELLED | — |
| 005 | Multi-vitamin preparations; [ vitamin A preparations; ] vitamin and mineral preparations for medical use; vitamin B preparations; vitamin C preparations; vitamin D preparations; vitamin preparations; vitamin supplements; vitamin tablets; vitamins; vitamins and vitamin preparations; botanical supplements for general health and well-being; botanical extracts for the treatment of colds and flu; botanical extracts for the treatment of inflammatory bowel disease and connective tissue diseases; botanical extracts for the treatment of stomach ulcers; herbal and dietary supplements for promoting faster muscle recovery after exercise; herbal supplements for general health and well-being; herbal supplements for the promotion of healthy liver function; herbal supplements for the treatment of cardiovascular diseases; herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases; herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries; herbal supplements for the treatment of the respiratory system; mineral supplements; beta carotene supplements; calcium supplements; dietary supplements for general health and well-being; [ dietary supplements for promoting weight loss; ] herbal supplements for the treatment of arthritis; nutritional supplements for general health and wellbeing; homeopathic remedies for the treatment of anxiety disorders; homeopathic remedies for the treatment of [ colds and flu; antioxidant pills; homeopathic remedies for the treatment of ] inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; mineral salts for medical purposes; folic acid; medicines for alleviating constipation; diarrhea medication; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; preparations for destroying parasites; intestinal disorder medicine for the treatment of irritable bowel syndrome; dietary fiber to aid digestion; gastrointestinal cleaning agents; intestinal disorder medicine for the treatment of ulcerative colitis; anti-viral agents; [ nail fungus treatment preparations; fungal medications; ] allergy medications; nasal drops for the treatment of allergies; [ ginseng capsules for general health and well-being; ] anti-inflammatories; anti-inflammatory preparations; anti-tussive expectorants; medicines for the treatment of gastrointestinal diseases; minerals for medical purposes; pain relief medication; diuretics; lipotropic factor preparations; medicines for adjusting the menstrual cycle; antiallergic medicines; nose drops; sleeping pills; preparations for the treatment of burns; acne medications; cough remedy; cough treatment medications; herbal supplements for use in dermatology, namely, dermatitis, eczema, psoriasis; [ homeopathic remedies for treatment of skin conditions, namely, dermatitis, eczema, psoriasis; ] anti-inflammatory and antipyretic preparations; antipyretic preparations; anthelmintics; anti-infectives; antiallergics; antidepressants; antihistamines; [ antimicrobials for dermatologic use; ] antiparasitic preparations; antiparasitics; antispasmodics; antitussives; antivirals; [ biological fungicides; ] botanical extracts for use in the treatment of dermatitis and skin pigmentation diseases; bronchodilating preparations; decongestants; expectorants; fertility enhancement preparations for human use; [ fungicides; fungicides for medical use; ] homeopathic remedies for the treatment of stomach ulcers; intestinal disorder medicine for the treatment of diverticular disease; laxatives; multivitamins; nasal spray preparations; sedatives [ ; vaginal antifungal preparations ] | ACTIVE | — |
| 041 | [ Organization of alternative medicine exhibition for educational purposes; organization of seminars, working groups, research groups and conventions, in the field of medicine and stress management; organization of conferences and symposia in the field of medical science and stress management ] | SECTION 8 - CANCELLED | May 23, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOMED INTERNATIONAL PRODUCTS CORPORATION
- Other trademarks owned by BIOMED INTERNATIONAL PRODUCTS CORPORATION
- Other trademarks owned by BIOMED INTERNATIONAL PRODUCTS CORPORATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 041
- Similar marks named BIOMED B
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2026 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 5, 2026 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jun 5, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 4, 2026 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Aug 6, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 6, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 3, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 2, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 2, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 1, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 1, 2019 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jun 19, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2019 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Jun 10, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 28, 2019 | IUAF | USE AMENDMENT FILED | — |
| May 28, 2019 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| May 28, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 28, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 28, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 27, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 2, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 2, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 12, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 13, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 9, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2017 | NWAP | NEW APPLICATION ENTERED | — |